Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fabrizio Quarantelli
Observed names:
F. Quarantelli,
Fabrizio QUARANTELLI
Institutions:
CEINGE Biotecnologie Avanzate Franco Salvatore (Italy),
University of Naples Federico II
Observed institutions:
CEINGE Biotecnologie Avanzate Franco Salvatore (Italy),
University of Turin,
University of Naples Federico II
ORCID:
0000-0003-0744-5734
Observed ORCID:
0000-0003-0744-5734
OpenAlex ID:
A5004650158
Long-chain polyphosphates impair SARS-CoV-2 infection and replication
2021
·
Veronica Ferrucci
, Dae-Young Kong
, et al.
·
Science Signaling
·
44
SARS-CoV-2 Subgenomic N (sgN) Transcripts in Oro-Nasopharyngeal Swabs Correlate with the Highest Viral Load, as Evaluated by Five Different Molecular Methods
2021
·
Massimo Zollo
, Veronica Ferrucci
, et al.
·
Diagnostics
·
31
PDF
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts
2020
·
Jessica Petiti
, Marco Lo Iacono
, et al.
·
Journal of Clinical Medicine
·
26
PDF
Identification of SARS-CoV‑2 Proteins from Nasopharyngeal Swabs Probed by Multiple Reaction Monitoring Tandem Mass Spectrometry
2021
·
Gabriella Pinto
, Anna Illiano
, et al.
·
ACS Omega
·
22
CML Patients with Low OCT-1 Activity Achieve Better Molecular Responses on High Dose Imatinib Than on Standard Dose. Those with High OCT-1 Activity Have Excellent Responses on Either Dose: A TOPS Correlative Study
2008
·
Deborah L White
, Verity A Saunders
, et al.
·
Blood
·
19
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
2007
·
Giuliana Alimena
, Massimo Breccia
, et al.
·
Leukemia Research
·
12
Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phase
2007
·
F. Palandri
, I. Iacobucci
, et al.
·
Haematologica
·
11
PDF
Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients—A Target for SARS-CoV-2 Propagation
2022
·
Veronica Ferrucci
, Pasqualino de Antonellis
, et al.
·
International Journal of Molecular Sciences
·
8
PDF
The Combination of Interferon-Alpha with Imatinib in Early Chronic Phase Chronic Myeloid Leukemia Patients Induces a Significant Improvement of the Molecular Responses in the First Two Years of Treatment: Results From Three Studies From the GIMEMA CML Working Party.
2009
·
Francesca Palandri
, Fausto Castagnetti
, et al.
·
Blood
·
7
The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial.
2008
·
Nicola Esposito
, Fabrizio Quarantelli
, et al.
·
Blood
·
5
An Automated Cartridge-Based Microfluidic System for Real-Time Quantification of BCR::ABL1 Transcripts in Chronic Myeloid Leukemia: An Italian Experience
2025
·
Alice Costanza Danzero
, Enrico Marco Gottardi
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
Targeted Therapy for a Rare PDGFRB-Rearranged Myeloproliferative Neoplasm: A Case Report
2026
·
Cosimo Barbato
, Vito A. Lasorsa
, et al.
·
International Journal of Molecular Sciences
·
1
PDF
Genexus: un nuovo approccio all-in-one di next generation sequencing nella diagnosi molecolare di leucemia mieloide acuta
2025
·
Alessandra POTENZA
, Roberta VISCONTI
, et al.
·
Biochimica Clinica
·
1
Specific Drug Transporter Genotypes Are Significantly Associated with Increased Rates of Major and Complete Molecular Responses In Newly Diagnosed Chronic Myeloid Leukemia Patients Treated with Imatinib – A TOPS Correlative Substudy
2010
·
Simona Soverini
, Sabrina Angelini
, et al.
·
Blood
·
1
Italian Standardization of Bcr-abl Rq-pcr and Quality Control Methods: an Overview of First 4 Years Results
2010
·
Barbara Izzo
, Fabrizio Quarantelli
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
·
1
Expression Profiling of ABC Transporter Genes in Chronic Myeloid Leukemia (CML) and Responsiveness to Imatinib
2008
·
Nunzio Iraci
, Simona Soverini
, et al.
·
Blood
·
1
Down-Modulation of Shp1 and Hsp70 Provides a Survival Advantage to the Ph+ Cells of CML Patients Additive to That Related to the Oncogenic BCR/ABL Protein and May Account for Resistance to Ima Treatment.
2007
·
Nicola Esposito
, Fabrizio Quarantelli
, et al.
·
Blood
·
1
Integrated Molecular and Cytogenomic Characterization of Acute Myeloid Leukaemia Reveals Hidden Clonal Architecture and Refines ELN Risk Stratification
2026
·
Alessandra Galdiero
, Alessandra Potenza
, et al.
·
Preprints.org
Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack® Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL Study
2026
·
Irene Della Starza
, Vittorio Bellomarino
, et al.
·
International Journal of Molecular Sciences
Correction: Danzero et al. An Automated Cartridge-Based Microfluidic System for Real-Time Quantification of BCR::ABL1 Transcripts in Chronic Myeloid Leukemia: An Italian Experience. Int. J. Mol. Sci. 2025, 26, 8932
2026
·
Alice Costanza Danzero
, Enrico Marco Gottardi
, et al.
·
International Journal of Molecular Sciences
PDF
Pb1981: Experience of Four Laboratories of the Italian Cml Labnet Network in the Use of the Cepheid Cartridge System
2023
·
Barbara Izzo
, Fabrizio Quarantelli
, et al.
·
HemaSphere
Association between genotypes and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the TOPS trial.
2010
·
Sabrina Angelini
, S. Poverini
, et al.
·
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
Association Between Imatinib (IM) Transporters and Metabolizing Enzymes Genotype and Response in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients (Pts) Is Influenced by Ethnicity.
2009
·
Simona Soverini
, Sabrina Angelini
, et al.
·
Blood
Association between transporters genotype and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the tops trial.
2009
·
Sabrina Angelini
, Simona Soverini
, et al.
·
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
Accuracy and Precision of Results After Implementation of Internationalscale to Evaluate Minimal Residual Disease in Chronic Myeloid Leukemiapatients Coordinated on Behalf of Gimema-cml Wp
2009
·
Fabrizio Quarantelli
, Barbara Izzo
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
Show more works
View as search
Works count:
32
Citation count:
193
H-index:
8
I10-index:
7
Year
Topic
Type